Science Quiz / Drugs MVST IB - part 1

Random Science Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

Forced Order
Score 0/156 Timer 20:00
DescriptionDrug nameUse
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
Reversible anticholinesterase - ionic interaction
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
Selective beta-1 antagonist (slight effect on beta-2)
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
Use-dependent block of ganglionic transmission
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
Nitrovasodilator - produces NO
Non-selective, reversible MAO inhibitor
Beta-1 antagonist used in heart failure
Blocks If current in SA node
Non-selective phosphodiesterase inhibitor
Class IC antidysrhythmic
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Progestagen receptor antagonist
Calcium channel agonist - dihydropyridine
Muscarinic receptor agonist
Progestagen receptor agonist
Plasminogen + anisoylated streptokinase
K channel opener - also NO donor
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
Potent, irreversible inhibitor of iNOS in activated macrophages
Carbonic anhydrase inhibitor
Non-selective phosphodiesterase inhibitor
Local anaesthetic - weak base - use-dependence and voltage-dependence
Orally-acting hypoglycaemic agent - sulphonylurea
Local anaesthetic - uncharged
Cholinergic agonist - +-isomer hydrolysed by AChE
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
ACE inhibitor
Class III antidysrhythmic - prolongs AP and refractory period
K channel opener - also hirsutism effects
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
NSAID used to prevent thrombosis
Direct acting vasodilator - metabolised to NO or cyanide
Non-specific endothelin receptor antagonist
Selective beta-2 agonist (slight effect on beta-1)
SSRI - blocks 5-HT transporter in Uptake 1
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
Selective alpha-2 antagonist (slight effect on alpha-1)
Depolarising blocker at NMJ
Involved with providing new blood flow to ischaemic tissues
Calcium channel blocker - benzothiazepine
Estrogen receptor antagonist
Selective beta-2 antagonist (slight effect on beta-1)
ACE inhibitor - prodrug, must be metabolised in liver
NOS inhibitor - not very selective for different forms
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
alpha-1 antagonist most commonly used
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
DescriptionDrug nameUse
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
Alpha-2 antagonist (some effect on alpha-1)
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
Illegal drug - blocks NET
Selective alpha-1 antagonist (slight effect on alpha-2)
Selective inhibitor of NOS in neurons
Mineralocorticoid receptor agonist
Non-selective agonist for muscarnic receptors
Selective MAO-A inhibitor
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Experimental cardiac glycoside
Beta-1 agonist - weak beta-2 agonist
Beta-adrenoceptor agonist
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
Inhibits HMG-CoA reductase - also many pleiotropic effects
Blocks transporter carrying ACh into storage vesicles
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Competitive inhibitor of tyrosine hydroxylase
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Phosphodiesterase III inhibitor - inodilator
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Glucocorticoid receptor antagonist
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Osmotic diuretic - filtered at glomerulus, not reabsorbed
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Selective antagonist for M1 muscarinic receptors
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
Non-selective beta-adrenoceptor antagonist
Glucocorticoid receptor agonist
Tyrosine kinase inhibitor
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Selective alpha-2 agonist
Irreversibly alkylates muscarinic receptor
Single chain recombinant human tissue plasminogen activator
Double chain recombinant human tissue plasminogen activator
Selective MAO-B inhibitor
Nitrovasodilator - produces NO - taken sublingually
Regulates expression of multiple angiogenic genes
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Binds to SNAREs involved in membrane fusion, preventing ACh release
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
COMT inhibitor
Interferes with normal function of microtubule growth
Mild partial beta-1 agonist
DescriptionDrug nameUse
Reverse inhibition of AChE by organophosphorus agents
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases
Arteriolar vasodilator - unknown mechanism
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Nitrovasodilator - produces NO - metabolised in liver to active drug
Local anaesthetic (ester, weak base) - broken down by BuChE
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
Causes development of new blood vessels
Non-selective agonist for muscarinic receptors
Phosphodiesterase III inhibitor - inodilator
K channel opener
Cardiac glycoside - inhibits Na/K-ATPase
Acts on imidazoline receptors
Binds to plasminogen activator, increasing generation of plasmin
Anion exchange resin - prevents reuptake of bile acids from intestine
Depolarising blocker selective for ganglion nicotinic receptor
Blocks Na channels from exterior - no use-dependence
PPAR-gamma agonist
Orally-acting hypoglycaemic agent - sulphonylurea
Inhibits DOPA decarboxylase in periphery
K channel opener
Irreversible anticholinesterase - organophosphorus agent
Non-selective alpha-adrenoceptor antagonist
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Tricyclic antidepressant - blocks NET
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
Immunosuppressant drug with antiproliferative effects
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Tricyclic antidepressant - blocks NET
Very potent alpha-2 agonist
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
Blocks uptake of choline into neurons
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Selective antagonist for M3 muscarinic receptor
Acts on imidazoline receptors
Combined alpha- and beta-adrenoceptor antagonist
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Selective alpha-1 agonist (some action on beta-1)
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Angiotensin II partial agonist
Non-peptide angiotensin II antagonist - acts on AT1 receptors
Binds to neurexins, causing massive ACh release from nerve terminals
Muscarinic receptor antagonist - very long duration of action
Estrogen receptor agonist
Beta-1 antagonist used in heart failure
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
A1 receptor antagonist - non-selective phosphodiesterase inhibitor

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
Log In

You Might Also Like...

Show Comments


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.